Modeling and Simulation in Bayesian Clinical Trial Design
Scott Berry, Berry Consultants *Gary L Rosner, Johns Hopkins University Keywords: Bayesian statistics, Modeling, Oncology Clinical studies in cancer are becoming more complex, especially in early phase studies. The complexity arises because of many factors, such as the desire to be more efficient than in the past, the need to address endpoints other than tumor shrinkage with newer targeted agents, and the current interest in determining the best drugs for the specific molecular characteristics of each tumor. Many studies that incorporate Bayesian ideas in their design often require modeling and simulation to help determine the best design or to evaluate each study's operating characteristics. In this talk, we will discuss several examples of designs that benefitted from modeling and simulation.
|
Key Dates
-
November 1 - December 17, 2013
Online proposal submission for a session, short course and Town Hall Open -
January 6 - March 11, 2014
Online proposal submission for Roundtables Open -
April 30 - May 28, 2014
Abstract Submission Open -
June 4, 2014
Online Registration Opens -
August 8 - August 22, 2014
Invited Abstract Editing -
August 11, 2014
Short Course materials due from Instructors -
September 1, 2014
Housing Deadline -
September 15, 2014
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 22 - September 24, 2014
Marriott Wardman Park, Washington, DC